ROYCE & ASSOCIATES LP - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 132 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$8,000
-77.1%
717
-85.7%
0.00%
Q3 2015$35,000
-28.6%
5,0000.0%0.00%
Q2 2015$49,000
+11.4%
5,0000.0%0.00%
Q1 2015$44,0000.0%5,0000.0%0.00%
Q4 2014$44,000
+29.4%
5,0000.0%0.00%
Q3 2014$34,000
-57.0%
5,000
-66.9%
0.00%
Q2 2014$79,000
+14.5%
15,1000.0%0.00%
Q1 2014$69,0000.0%15,100
+10.2%
0.00%
Q4 2013$69,0000.0%13,7000.0%0.00%
Q3 2013$69,000
+19.0%
13,700
+17.1%
0.00%
Q2 2013$58,00011,7000.00%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Athos Capital Ltd 410,389$4,596,0003.46%
GLG Partners LP 2,586,437$28,968,0001.54%
Nine Chapters Capital Management LLC 32,300$362,0000.80%
FNY Partners Fund LP 335,900$3,762,0000.64%
MENTA CAPITAL LLC 373,523$4,183,0000.61%
Yakira Capital Management, Inc. 85,500$958,0000.32%
Sapphire Star Partners LP 18,724$209,0000.27%
GAM Holding AG 541,025$6,059,0000.26%
Bowling Portfolio Management LLC 127,873$1,432,0000.22%
Kassirer Asset Management Corp 15,000$168,0000.16%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders